Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model

Autologous neural stem cells (NSCs) may offer a promising source for deriving dopaminergic (DA) cells for treatment of Parkinson's disease (PD). Methods: By using Sendai virus, human peripheral blood mononuclear cells (PBMNCs) were reprogrammed to induced NSCs (iNSCs), which were then different...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yanpeng, Tang, Xihe, Bai, Yun-Fei, Wang, Shuyan, An, Jing, Wu, Yanchuan, Xu, Zhi-Qing David, Zhang, Y. Alex, Chen, Zhiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160767/
https://www.ncbi.nlm.nih.gov/pubmed/30279731
http://dx.doi.org/10.7150/thno.26643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160767/
https://www.ncbi.nlm.nih.gov/pubmed/30279731
http://dx.doi.org/10.7150/thno.26643

Ejemplares similares